STE STERIS PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: STE
- PE Ratio
As at Jun 5, 2025, the STE stock has a PE ratio of 39.04. This is based on the current EPS of $6.24 and the stock price of $243.58 per share. A decrease of 17% has been seen in the P/E ratio compared to the average of 47.3 of the last 4 quarters.
STE PE ratio history
The mean historical PE ratio of STERIS over the last ten years is 52.85. The current 39.04 PE ratio is 26% below the historical average. Over the past ten years, STE's PE ratio was at its highest in the Jun 2023 quarter at 185.93, with a price of $224.98 and an EPS of $1.21. The Mar 2018 quarter recorded the bottom point at 27.3, with a price of $93.36 and an EPS of $3.42.
STERIS PE ratio by year
Maximum annual increase: 136.57% in 2022
Maximum annual decrease: -67.16% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 36.32 | -38.13% | $226.65 | $6.24 |
| 2024 | 58.7 | -67.16% | $224.82 | $3.83 |
| 2023 | 178.77 | 84.85% | $191.28 | $1.07 |
| 2022 | 96.71 | 136.57% | $241.77 | $2.5 |
| 2021 | 40.88 | 40.48% | $190.48 | $4.66 |
| 2020 | 29.1 | -18.4% | $139.97 | $4.81 |
| 2019 | 35.66 | 30.62% | $128.03 | $3.59 |
| 2018 | 27.3 | -49.29% | $93.36 | $3.42 |
| 2017 | 53.84 | 18.98% | $69.46 | $1.29 |
| 2016 | 45.25 | N/A | $71.05 | $1.57 |
| 2015 | N/A | N/A | N/A | $2.27 |
| 2014 | N/A | N/A | N/A | $2.2 |
| 2013 | N/A | N/A | N/A | $79.5 |
| 2012 | N/A | N/A | N/A | $66.77 |
STERIS PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 36.32 | -16.26% | $226.65 | $6.24 |
| Dec 2024 | 43.37 | -21.32% | $205.56 | $4.74 |
| Sep 2024 | 55.12 | 1.68% | $242.54 | $4.4 |
| Jun 2024 | 54.21 | -7.65% | $219.54 | $4.05 |
| Mar 2024 | 58.7 | 52.47% | $224.82 | $3.83 |
| Dec 2023 | 38.5 | -2.97% | $219.85 | $5.71 |
| Sep 2023 | 39.68 | -78.66% | $219.42 | $5.53 |
| Jun 2023 | 185.93 | 4.01% | $224.98 | $1.21 |
| Mar 2023 | 178.77 | N/A | $191.28 | $1.07 |
| Dec 2022 | N/A | N/A | $184.69 | -$0.28 |
| Sep 2022 | N/A | N/A | $166.28 | -$0.08 |
| Jun 2022 | 54.68 | -43.46% | $206.15 | $3.77 |
| Mar 2022 | 96.71 | 16.01% | $241.77 | $2.5 |
| Dec 2021 | 83.36 | 15.07% | $243.41 | $2.92 |
| Sep 2021 | 72.44 | 17.98% | $204.28 | $2.82 |
STE Price vs fair value
STE average PE ratio chart
Currently, STE's PE ratio is below the 3 and 5-year averages.
STE PE vs peers
STE's PE ratio is lower than its peer stock SYK, but it is greater than JNJ's and TMO's. STERIS's current PE ratio of 39.04 is above the average of its peers, which is 25.55.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CNMD CONMED Corp | 14.89 | $1.77B |
| JNJ Johnson & Johnson | 17.14 | $373.64B |
| KMB Kimberly Clark Corp | 18.15 | $44.39B |
| MMM 3M Co | 18.57 | $79.56B |
| TMO Thermo Fisher Scientific Inc | 23.71 | $152.98B |
| ECL Ecolab Inc | 36.15 | $75.94B |
| STE STERIS plc | 39.13 | $24.02B |
| SYK Stryker Corp | 51.55 | $147.74B |
| OMI Owens & Minor Inc | N/A | $577.67M |
Frequently asked questions
What is STERIS's PE ratio?
STE's price to earnings ratio is 39.04 as of Jun 5, 2025.
What is the 3-year average PE ratio for STERIS (STE)?
The 3-year average PE ratio for STE stock is 74.53.
What is the 5-year average PE ratio for STERIS (STE)?
The 5-year average PE ratio for STE stock is 66.9.
What is the highest PE ratio for STE?
In the last ten years, the Jun 2023 quarter recorded the highest quarterly PE ratio at 185.93.
How does the current PE ratio for STE compare to its historical average?
STE's current price to earnings ratio is 26% below its 10-year historical average.
How is STE's PE ratio calculated (STERIS PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 5, 2025), STERIS's stock price is $243.58. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $6.24. Therefore, STERIS's P/E ratio for today is 39.04. PE RATIO(39.04) = STOCK PRICE($243.58) / TTM EPS($6.24)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.